Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) Short Interest Down 52.0% in August

Zhengye Biotechnology Holding Limited (NASDAQ:ZYBT) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 173,858 shares, a drop of 52.0% from the August 15th total of 362,103 shares. Currently, 0.4% of the shares of the company are sold short. Based on an average daily trading volume, of 247,213 shares, the short-interest ratio is currently 0.7 days.

Institutional Trading of Zhengye Biotechnology

Large investors have recently made changes to their positions in the business. Geode Capital Management LLC purchased a new position in shares of Zhengye Biotechnology during the second quarter worth $174,000. Invesco Ltd. acquired a new stake in Zhengye Biotechnology during the 2nd quarter worth about $220,000. Jane Street Group LLC acquired a new stake in Zhengye Biotechnology during the 2nd quarter worth about $1,158,000. WINTON GROUP Ltd purchased a new position in shares of Zhengye Biotechnology during the 3rd quarter valued at about $56,000. Finally, Citadel Advisors LLC purchased a new position in shares of Zhengye Biotechnology during the 3rd quarter valued at about $31,000.

Zhengye Biotechnology Stock Performance

Shares of NASDAQ ZYBT opened at $1.55 on Monday. Zhengye Biotechnology has a 52 week low of $0.62 and a 52 week high of $11.45. The business’s 50 day moving average price is $1.62 and its 200 day moving average price is $1.13. The company has a current ratio of 1.14, a quick ratio of 0.82 and a debt-to-equity ratio of 0.03.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Zhengye Biotechnology from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday, July 20th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has an average rating of “Sell”.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.